PORTLAND, OR--(Marketwire - Dec 6, 2012) - Molecu
Post# of 617763
Posted On: 12/06/2012 12:00:03 PM
PORTLAND, OR--(Marketwire - Dec 6, 2012) - MolecularMD Corp. announced today that it will present data at the annual meeting of the American Society of Hematology conference, pertaining to the development of a Next Generation Sequencing (NGS) test for detection of resistant mutations in patients diagnosed with Chronic Myelogenous Leukemia (CML).
View More
View More
(0)
(0)